ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

$0.74
+0.06 (+8.26%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,972.5% upside
Low Target $15.82
Average Target $22.62
High Target $24.89
Current Price $0.74
Current
$0.74
Target
$22.62
$15.82 $22.62 avg $24.89
Scenario Analysis
Bear Case
$15.82
2,048.9%
Low target
Base Case
$22.62
+2,972.5%
Avg target
Bull Case
$24.89
+3,280.9%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$8.49
-91.3% from high
52-Week Low
$0.72
+2.3% from low
Target vs 52W High
$22.62
+166.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.6%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%